DE3786317T2 - Proteinanaloge des gewebs-plasminogenaktivators. - Google Patents

Proteinanaloge des gewebs-plasminogenaktivators.

Info

Publication number
DE3786317T2
DE3786317T2 DE87903044T DE3786317T DE3786317T2 DE 3786317 T2 DE3786317 T2 DE 3786317T2 DE 87903044 T DE87903044 T DE 87903044T DE 3786317 T DE3786317 T DE 3786317T DE 3786317 T2 DE3786317 T2 DE 3786317T2
Authority
DE
Germany
Prior art keywords
tpa
analogues
fragment
fibrin binding
natural
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE87903044T
Other languages
English (en)
Other versions
DE3786317D1 (de
Inventor
Roberto Crea
Roy Ho Loi Pang
Hermann Oppermann
Peter C Keck
Gabriel Alvarado-Urbina
Gay-May Wu
Charles M Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Menarini Industrie Farmaceutiche Riunite SRL
Creative Biomolecules Inc
Original Assignee
Menarini Industrie Farmaceutiche Riunite SRL
Creative Biomolecules Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Industrie Farmaceutiche Riunite SRL, Creative Biomolecules Inc filed Critical Menarini Industrie Farmaceutiche Riunite SRL
Application granted granted Critical
Publication of DE3786317D1 publication Critical patent/DE3786317D1/de
Publication of DE3786317T2 publication Critical patent/DE3786317T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424Serine endopeptidases (3.4.21)
    • C12N9/6456Plasminogen activators
    • C12N9/6459Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21069Protein C activated (3.4.21.69)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE87903044T 1986-03-28 1987-03-26 Proteinanaloge des gewebs-plasminogenaktivators. Expired - Fee Related DE3786317T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84554186A 1986-03-28 1986-03-28
US2933687A 1987-03-23 1987-03-23

Publications (2)

Publication Number Publication Date
DE3786317D1 DE3786317D1 (de) 1993-07-29
DE3786317T2 true DE3786317T2 (de) 1994-02-03

Family

ID=26704839

Family Applications (1)

Application Number Title Priority Date Filing Date
DE87903044T Expired - Fee Related DE3786317T2 (de) 1986-03-28 1987-03-26 Proteinanaloge des gewebs-plasminogenaktivators.

Country Status (5)

Country Link
EP (1) EP0263172B1 (de)
AT (1) ATE90967T1 (de)
AU (1) AU7282687A (de)
DE (1) DE3786317T2 (de)
WO (1) WO1987005934A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK623186A (da) * 1985-12-23 1987-08-26 Chiron Corp Polypeptid med vaevsplasminogen-aktivator-virkning
CA1339445C (en) * 1986-11-12 1997-09-09 The General Hospital Corporation Recombinant hybrid immunoglobulin molecules and method of use
GB8705377D0 (en) * 1987-03-07 1987-04-08 Beecham Group Plc Compounds
GB8711957D0 (en) * 1987-05-20 1987-06-24 Beecham Group Plc Compounds
US5149533A (en) * 1987-06-04 1992-09-22 Zymogenetics, Inc. Modified t-PA with kringle-/replaced by another kringle
US5302390A (en) * 1987-07-01 1994-04-12 Beecham Group Plc Hybrid proteins of human plasminogen and human t-PA, pharmaceutical compositions and methods of treatment
JPH02438A (ja) * 1987-10-09 1990-01-05 Collaborative Res Inc 修飾した低分子量プラスミノーゲン活性化因子およびその製造方法
US5372812A (en) * 1988-04-04 1994-12-13 The General Hospital Corporation Composition and method for acceleration of clot lysis
US5582862A (en) * 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
KR900702017A (ko) * 1988-06-03 1990-12-05 존 로버트 버쉬 혼성 단백질(bybrid proteins)
DK176140B1 (da) * 1988-07-20 2006-09-25 Schering Ag Patentabteilung Flagermusspyt-plasminogenaktivatorer
US5609869A (en) * 1988-08-19 1997-03-11 The General Hospital Corporation Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use
US5811265A (en) * 1988-08-19 1998-09-22 The General Hospital Corporation Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use
DE3942580A1 (de) * 1989-12-22 1991-06-27 Basf Ag Verfahren zur herstellung von hirudin
CA2266339A1 (en) * 1996-09-20 1998-03-26 The General Hospital Corporation Chimeric, humanized and single chain antibodies to alpha-2-antiplasmin

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR79202B (de) * 1982-05-05 1984-10-22 Genentech Inc
EP0289508A1 (de) * 1985-12-20 1988-11-09 The Upjohn Company Analoge des gewebespezifischen plasminogenaktivators
EP0234051B1 (de) * 1986-02-17 1991-12-11 Stichting Centraal Laboratorium van de Bloedtransfusiedienst van het Nederlandse Rode Kruis Gewebeplasminogen-Aktivator-Mutant, dafür kodierende rekombinante genetische Information und Verfahren zur Herstellung dieser Mutanten, deren Verwendung und pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
AU7282687A (en) 1987-10-20
EP0263172B1 (de) 1993-06-23
EP0263172A1 (de) 1988-04-13
DE3786317D1 (de) 1993-07-29
ATE90967T1 (de) 1993-07-15
WO1987005934A1 (en) 1987-10-08

Similar Documents

Publication Publication Date Title
DE3786317T2 (de) Proteinanaloge des gewebs-plasminogenaktivators.
ES2187527T3 (es) Estructura de orden superior y enlace de acidos nucleicos peptidicos.
BG100771A (en) Hematopoeic protein and ways and methods for its preparation
KR970707153A (ko) 카텝신 02 프로테아제(cathepsin 02 protease)
DE69929886D1 (de) Überexpression von phytase in hefesystemen
DK0618976T3 (da) Syntetisk DNA-sekvens med forbedret insekticid virkning i majs
DE112006000677A5 (de) Rekombinante Expression von Proteinen in einer disulfidverbrückten, zweikettigen Form
IE831024L (en) Human tissue plasminogen activator
ATE74379T1 (de) Peptidplasminogenaktivatoren.
ATE270330T1 (de) Alpha untereinheit des humanen beta-2 integrins
EP1009752A4 (de) Neue moleküle aus der familieder tango-77-ähnlichen proteine und ihre verewendungen.
AU3217100A (en) Methods of use of a novel lysyl oxidase-related protein
WO1994021800A3 (en) Protein tyrosine phosphatase ptp-s31
DE69735207D1 (de) Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt
WO1994003611A3 (en) Ptp-d subfamily of protein tyrosine phosphatases
DE60015988D1 (de) Modifizierung von schaumeigenschaften von proteinen
ES2232860T3 (es) Proteinas recombinantes de ribonucleasa.
KR870001311A (ko) 단백질 및 폴리펩티드의 제조 방법
DK0901526T3 (da) Cortistatin: neuropeptider, sammensætninger og metoder
ATE291088T1 (de) Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe
KR900702017A (ko) 혼성 단백질(bybrid proteins)
DK0805204T3 (da) Bitestikel - specifikt receptorprotein og anvendelse heraf
Williams et al. Dye-ligand affinity purification of human complement factor B and β2 glycoprotein I
DE60023933D1 (en) Hybrid-toxine von bacillus thuringiensis
PT1379639E (pt) A glucuranilo epimerase c5 o dna que a codifica e as suas utilizacoes

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee